Evidence map›Paper›PMID 40921758›Full record

ReviewNature protocols2026

A versatile toolkit for drug metabolism studies with GNPS2: from drug development to clinical monitoring.

Jun Sang Yu, Young Beom Kwak, Kyung Hwa Kee, Mingxun Wang, Dong Hyun Kim, Pieter C Dorrestein, Kyo Bin Kang, Hye Hyun Yoo

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jun Sang YuPharmacomicrobiomics Research Center and College of Pharmacy, Hanyang University, Ansan, Republic of Korea.ORCID 0000-0002-5720-5934
Young Beom KwakDepartment of Pharmaceutical Engineering, Inje University, Gimhae, Republic of Korea.
Kyung Hwa KeePharmacomicrobiomics Research Center and College of Pharmacy, Hanyang University, Ansan, Republic of Korea.ORCID 0009-0007-6973-7843
Mingxun WangDepartment of Computer Science and Engineering, University of California Riverside, Riverside, CA, USA.ORCID 0000-0001-7647-6097
Dong Hyun KimDepartment of Pharmacology, Inje University College of Medicine, Busan, Republic of Korea.
Pieter C DorresteinSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, USA.ORCID 0000-0002-3003-1030
Kyo Bin KangCollege of Pharmacy and Research Institute of Pharmaceutical Sciences, Sookmyung Women's University, Seoul, Republic of Korea. kbkang@sookmyung.ac.kr.ORCID 0000-0003-3290-1017
Hye Hyun YooPharmacomicrobiomics Research Center and College of Pharmacy, Hanyang University, Ansan, Republic of Korea. yoohh@hanyang.ac.kr.ORCID 0000-0001-8282-852X

Funding

Project 4 - Mechanistic studies on the role of the gut microbiome in models for Alzheimer's diseaseU19AG063744 · NIA · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ROB KNIGHT, Rima F Kaddurah-Daouk · 2019 to 2026
$54.1M
Korea Basic Science Institute (KBSI) RS-2024-00436674National Research Foundation of Korea (NRF) RS-2023-00217123National Research Foundation of Korea (NRF) RS-2025-00523337, RS-2022-NR070845, RS-2022-NR068419U.S. Department of Energy (DOE) DE-AC02-05CH11231U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) U19AG063744U.S. Department of Health and Human Services (U.S. Department of Health & Human Services) 5U24DK133658
6 · The paper itself

Abstract

Metabolism is a fundamental process that shapes the pharmacological and toxicological profiles of drugs, making metabolite identification and analysis critical in drug development and biological research. Global Natural Products Social Networking (GNPS) is a community-driven infrastructure for mass spectrometry data analysis, storage and knowledge dissemination. GNPS2 is an improved version of the platform offering higher processing speeds, improved data analysis tools and a more intuitive user interface. Molecular networking based on tandem mass spectrometry spectral alignments, combined with other tools in the GNPS2 analysis environment, enables the discovery of candidate drug metabolites without prior knowledge, even from complex biological matrices. This protocol represents an extension of a previously established protocol for fundamental molecular networking in GNPS, with a specific focus on metabolism studies. This article uses the example of the drug sildenafil to identify candidate metabolites obtained from liquid chromatography-quadrupole time-of-flight mass spectrometry analysis of liver microsomal fractions and mice plasma to guide the reader through a step-by-step process consisting of five GNPS2-based analytical workflows. It demonstrates how the tools in GNPS2 can be used not only to identify candidate drug metabolites from in vitro studies but also to evaluate the translational relevance of these in vitro findings to humans by using reverse metabolomics. We provide a step-by-step analytical approach based on published studies to showcase how GNPS2 can be effectively applied in drug metabolism studies.

Indexed as

Drug DevelopmentSoftwareAnimalsChromatography, LiquidHumansMass SpectrometryMiceMicrosomes, LiverPharmaceutical PreparationsSildenafil CitrateTandem Mass SpectrometryPharmaceutical PreparationsSildenafil Citrate

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.